Looks like it is going to cost Merck $253.4 million to make up for their Vioxx screw up. It may cost them even more:
If the first wave of verdicts go against Merck, experts predict it will open the floodgates for more lawsuits and could force the drug company to settle cases. Analysts have speculated Merck's liability could reach $18 billion.
That would seriously hurt their bottom line and create quite a bit on uncertainty for this stock. It may be a decent short candidate in the coming months.
No comments:
Post a Comment